Scientific Board

  • Prof. Oliver Planz, Ph.D. (Chair)

    Universität D-Tübingen,Co-inventor of the technology, expert in antiviral research und translational preclinical R&D up to clinical studies. Advises the WHO on antiviral strategies against influenza.

  • Prof. Stephan Ludwig, Ph.D.

    Universität D-Münster, Co-inventor of the technology, globally renowned expert in influenza virus-cell interactions. Over 150 scientific publications and more than 10 patents.

  • Prof. Stephan Pleschka, Ph.D.

    Universität D-Gießen, Co-inventor of the technology. Expert in replication, infection and cell-virus interactions of the influenza virus. Advisor to biotech companies.

  • 1

Address

Atriva Therapeutics GmbH
Christophstr. 32, 72072 Tübingen

+49 (0)7071 8597673
info@atriva-therapeutics.com

In order to be able to design our website in the best possible way and to continuously improve it, we are using cookies. By continuing to use our website, you permit the use of cookies. More information can be found in our data protection rules.
Data Protection Rules I Agree